data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italian
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italian
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Opthea
(NASDAQ:OPT)
7.04
0.04[0.57%]
Last update: 10:34AM
15 minutes delayed
Day High/Low7 - 7.35
52 Week High/Low4.73 - 16.23
Open / Close7.14 / -
Float / Outstanding- / 44M
Vol / Avg.4.6K / 4.3K
Mkt Cap309.7M
P/E-
50d Avg. Price6.16
Div / Yield-
Payout Ratio-
EPS-
Total Float-

Opthea (NASDAQ:OPT), Quotes and News Summary

Opthea (NASDAQ: OPT)

Day High/Low7 - 7.35
52 Week High/Low4.73 - 16.23
Open / Close7.14 / -
Float / Outstanding- / 44M
Vol / Avg.4.6K / 4.3K
Mkt Cap309.7M
P/E-
50d Avg. Price6.16
Div / Yield-
Payout Ratio-
EPS-
Total Float-
Benzinga - Apr 26, 2022, 9:37AM
Benzinga - Feb 14, 2022, 9:06AM
Benzinga - Oct 26, 2021, 6:07AM
Benzinga - Oct 19, 2021, 6:04AM
Benzinga - Oct 4, 2021, 7:06AM
Benzinga - Jul 6, 2021, 7:52AM
Benzinga - Jul 6, 2021, 7:05AM
Benzinga - Jun 16, 2021, 10:28AM
Benzinga - Jun 16, 2021, 10:16AM
Benzinga - Jun 16, 2021, 10:03AM
load more
Sector: Health Care.Industry: Biotechnology
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.
Read More

Earnings

see more
FY 2022Est.ActualSurprise
EPS
(EXPECTED)2022-06-07
REV
H1 2022Est.ActualSurprise
EPS-0.107
REV91.218K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Opthea Questions & Answers

Q
How do I buy Opthea (OPT) stock?
A

You can purchase shares of Opthea (NASDAQ: OPT) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Opthea's (OPT) competitors?
Q
What is the target price for Opthea (OPT) stock?
A

The latest price target for Opthea (NASDAQ: OPT) was reported by SVB Leerink on Tuesday, April 26, 2022. The analyst firm set a price target for 25.00 expecting OPT to rise to within 12 months (a possible 255.11% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Opthea (OPT)?
A

The stock price for Opthea (NASDAQ: OPT) is $7.04 last updated Today at May 26, 2022, 2:34 PM UTC.

Q
Does Opthea (OPT) pay a dividend?
A

There are no upcoming dividends for Opthea.

Q
When is Opthea (NASDAQ:OPT) reporting earnings?
A

Opthea’s FY earnings are confirmed for Tuesday, June 7, 2022.

Q
Is Opthea (OPT) going to split?
A

There is no upcoming split for Opthea.

Q
What sector and industry does Opthea (OPT) operate in?
A

Opthea is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.